New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years.
about
HLA-matched sibling bone marrow transplantation for β-thalassemia majorT cell-depleted hla-haploidentical stem cell transplantation in thalassemia young patientsCurrent and future alternative therapies for beta-thalassemia majorResidual NADPH oxidase and survival in chronic granulomatous diseaseHematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin.Escalating doses of donor lymphocytes for incipient graft rejection following SCT for thalassemia.Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel.Reduction of intramedullary apoptosis after stem cell transplantation in black african variant of pediatric sickle cell anemia.Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis.Hematopoietic stem cell transplantation in thalassemia and sickle cell disease. Unicenter experience in a multi-ethnic populationCost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program.Improved clinical outcomes of high risk β thalassemia major patients undergoing a HLA matched related allogeneic stem cell transplant with a treosulfan based conditioning regimen and peripheral blood stem cell graftsPretransplant immunosuppression followed by reduced-toxicity conditioning and stem cell transplantation in high-risk thalassemia: a safe approach to disease controlNew frontiers in pediatric Allo-SCT.Haematopoietic stem cell transplantation in Nigerian sickle cell anaemia children patientsHematopoietic stem cell transplantation for homozygous β-thalassemia and β-thalassemia/hemoglobin E patients from haploidentical donors.Hematopoietic transplantation for bone marrow failure syndromes and thalassemia.Outcome of match related allogeneic stem cell transplantation procedures performed from 2004 till 2011Influence of glutathione S-transferase gene polymorphisms on busulfan pharmacokinetics and outcome of hematopoietic stem-cell transplantation in thalassemia pediatric patientsUnrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)The thalassaemia syndromes.Frequency and Outcome of Graft versus Host Disease after Stem Cell Transplantation: A Six-Year Experience from a Tertiary Care Center in Pakistan.Graft failure after allogeneic hematopoietic cell transplantationRelationship between mixed chimerism and rejection after bone marrow transplantation in thalassaemia.Cord blood stem cell transplantation for haemoglobinopathies.Regional consensus opinion for the management of Beta thalassemia major in the Arabian Gulf areaSetting up low-risk bone marrow transplantation for children with thalassemia may facilitate pediatric cancer care.The impact of hematopoietic stem cell transplantation on the management of thalassemia.Gauchers disease--a reappraisal of hematopoietic stem cell transplantation.Conditioning regimens in allo-SCT for thalassemia major.Mixed chimerism in haemoglobinopathies: from risk of graft rejection to immune tolerance.Thalassaemia in children: from quality of care to quality of life.Non-invasive prenatal diagnosis of β-thalassemia by detection of the cell-free fetal DNA in maternal circulation: a systematic review and meta-analysis.Unrelated donor stem cell transplantation for transfusion-dependent thalassemia.Cure for thalassemia major - from allogeneic hematopoietic stem cell transplantation to gene therapy.Clinical comparison of weight- and age-based strategy of dose administration in children receiving intravenous busulfan for hematopoietic stem cell transplantation.Outcomes of thalassemia patients undergoing hematopoietic stem cell transplantation by using a standard myeloablative versus a novel reduced-toxicity conditioning regimen according to a new risk stratificationInfectious complications following allogeneic stem cell transplantation by using anti-thymocyte globulin-based myeloablative conditioning regimens in children with hemoglobinopathies.Hematopietic stem cell transplantation in thalassemia and related disorders.Glutathione S-transferase T1-null seems to be associated with graft failure in hematopoietic SCT.
P2860
Q24600037-E9AB9765-29DF-45F2-A7CD-A38D21033CE8Q24632544-D4AE22E7-3FA9-40FC-8C0D-6869C7BA33ADQ26750906-E95FBF0D-3BC0-4FEF-AA1B-03A9DFEAC301Q28301969-28845C6B-67A1-46FF-9014-DB15A64B85A4Q33363625-5620B593-A60A-45B9-99DA-7A8BBCACAFB4Q33386915-88798304-D168-4A84-91A3-649F1A405BCFQ33558770-DB6CD6DF-7D25-4079-8CAD-6E020C173700Q33920142-A8B6C308-1E0C-4D9B-AA87-53DCFFF4DDE4Q34207677-DF5D8689-0498-4FFC-AAF5-7ED8825D3234Q34549438-DBDF3BED-7CD1-4DE6-BD15-AE9888E060CDQ34573919-31A311FC-AC40-427B-9C8F-9780A5BB9EE9Q34700498-938CAF24-398C-4B69-89CB-68AA86F76E57Q35600557-FCE08F52-2FF5-41E9-A89E-323F0F043184Q35628739-EA8AD585-809A-4940-A9A4-E86D33017BB1Q35898546-EBF798DC-5363-49FC-98F4-DBDE96778A6EQ35924098-1504B7AB-F23B-4D1D-A426-0A84161DAA59Q36090202-A15D2A08-D348-4D58-AD65-BC0B1A0FFD36Q36444449-2D97736A-FB60-4167-B95F-166F87D89219Q36650481-CC0C8228-1932-4888-A747-05DFF7F43C8EQ36745209-29211E58-8971-4BA0-93E2-EC92B7B3112DQ36762089-8C65DD97-D4FA-407D-B227-5F4DD1287C45Q37015550-B1F39173-E8B8-4A98-BACB-004BB17E4074Q37045988-EC24B560-A1F0-4E29-81A8-BF63FAC49E6FQ37062428-3AA35FCA-3DDE-42F6-B2DD-ABABFF6B4B2CQ37096984-0AE93E72-A150-42C1-B3EF-A07F1E9E94ADQ37359617-44738E1A-8DDC-497B-9A3F-B350698F66FEQ37481685-EFE76979-66D5-4B01-ADB5-82E469C60208Q37810097-DB26C41B-C66A-4B75-B113-514F64B7BD8AQ38077831-B4E8D689-02D5-4F73-B8E3-8B84894FC8CFQ38179977-B5EAC90C-0D03-4BDA-B957-32F6AFA9DE38Q38191280-D3781B73-2B48-4F9F-BD61-ACED4877D7ABQ38569638-2FB0EF58-157D-4E5A-B9FA-2014188484D9Q38770436-8C8583D3-3A71-499F-B2DD-215942B50E54Q38783216-97084CC4-8167-4886-888E-DA789E7D2A85Q39026510-8CD26249-A983-4367-8C98-A8BEAF254CE9Q40170434-3F9641A7-0C4E-49DC-9746-3664135D0DD8Q41201160-113AD4E9-839F-4EE6-9D74-1C710DF81431Q41489129-A7C46FAE-670A-4956-B16C-1E140B17808FQ42588942-FE6BD9D2-1F5C-4157-844B-C410C000FA80Q43116241-00E18B56-8891-4AEF-96C5-CC82F1AE5948
P2860
New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
New approach for bone marrow t ...... ia aged younger than 17 years.
@en
New approach for bone marrow t ...... ia aged younger than 17 years.
@nl
type
label
New approach for bone marrow t ...... ia aged younger than 17 years.
@en
New approach for bone marrow t ...... ia aged younger than 17 years.
@nl
prefLabel
New approach for bone marrow t ...... ia aged younger than 17 years.
@en
New approach for bone marrow t ...... ia aged younger than 17 years.
@nl
P2093
P1433
P1476
New approach for bone marrow t ...... ia aged younger than 17 years.
@en
P2093
Barbarella Lucarelli
Buket Erer
Claudio Giardini
David Gaziev
Donatella Baronciani
Guido Lucarelli
Marco Andreani
Marisa Manna
Paola Polchi
Pietro Sodani
P304
P356
10.1182/BLOOD-2003-08-2800
P407
P577
2004-03-23T00:00:00Z